Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- U.S. drug overdose deaths
- The state of opioid misuse in America (2017)
- What is pain?
- The types of pain
- Opioids are the mainstream of pain treatment
- Opioid receptors
- Mu opioid analgesics
- Mu opioid actions are complex
- The holy grail of opioid analgesics
- Approaches to develop opioids lacking side-effects
- Mu opioid receptor gene: OPRM1
- Splice variants
- OPRM1 alternative splicing
- Splice variants: truncated 6TM variant
- Gene targeting mouse model studies
- IBNtxA
- 125I-IBNtxA binding in triple KO mouse brain
- Gain-of-function study: lentiviral rescue (1)
- Gain-of-function study: lentiviral rescue (2)
- Gain-of-function study: lentiviral rescue of 6TM
- IBNtxA: side-effects in WT mice
- Pharmacological profiles of 7TM and 6TM compounds
- Other 6TM variants involved
- Summary of KO mouse studies
- Translate basic science into drug development
- Summary
- Acknowledgements
- Thank you for your attention
Topics Covered
- Mu opioid receptor
- Opioids
- Morphine
- Alternative splicing of OPRM1
- Analgesia
- 3’-iodobenzoyl-6beta-naltrexamide (IBNtxA)
- Lentivirus analgesia rescue
Talk Citation
Pan, Y. (2022, October 31). Safer opioid analgesics: targeting truncated Mu opioid receptor splice variants [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/UASK7541.Export Citation (RIS)
Publication History
Financial Disclosures
- Ying-Xian Pan is a co-scientific founder of Sparian Biosciences.
Safer opioid analgesics: targeting truncated Mu opioid receptor splice variants
Published on October 31, 2022
29 min
A selection of talks on Genetics & Epigenetics
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Ying-Xian Pan.
I'm a Professor at the
Department of Anesthesiology,
Rutgers New Jersey
Medical School.
My research interests
have long focused
on the mechanism and the
function of opioid actions,
particularly as a route
to Mu opioid receptors.
Today, I will talk about
one of our stories,
how to translate our basic
science into the development of
normal opioid analgesics that are
potent, but lack side effects.
0:34
This slide shows drug overdose
deaths in the US in 2017.
About 70K overdoses
for all drugs
and about 47K for opioid
overdose deaths is more than
two-thirds of all
drug overdose deaths,
which also is the
driving force behind
this steep increase in the
death rate in recent years.
1:01
One main reason for
opioid overdose deaths is
opioid misuse through
either prescription
or illegal routes.
This slide shows that in 2017,
about 11 million people
misused opioids and
about 20 percent of the 2.1 million
people developed opioid use disorder.
However, the main reason for opioid
misuse is pain-over 62 percent.
What is pain?
1:34
The word pain comes from Latin,
Peona or Greek Poine,
meaning punishment or penalty.
Based on the International
Association for the Study of Pain,
pain is defined as an
unpleasant sensory
and emotional experience
associated with or
resembling that is
associated with
actual or potential
tissue damage
or described in terms
of such damage.
Pain is subjective
and protective, and
is modified by
developmental-behavioral,
personality, and
cultural factors.
Pain is the most common symptom
leading to physician contact.
Pain is the main reason for
opioid misuse contributing to
the worldwide opioid epidemic.
Hide